Global Hemostats Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Hemostats Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

According to APO Research, The global Hemostats market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hemostats is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Hemostats is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Hemostats is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Hemostats is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Hemostats include Ethicon, Pfizer, Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences Corporation and B Braun Melsungen AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hemostats, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Hemostats, also provides the sales of main regions and countries. Of the upcoming market potential for Hemostats, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hemostats sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Hemostats market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Hemostats sales, projected growth trends, production technology, application and end-user industry.

Hemostats segment by Company

Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
Hemostats segment by Type

Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Hemostats segment by Application

Prehospital Treatment
Hospital Treatment
Hemostats segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostats market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemostats and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostats.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemostats market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemostats manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemostats in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Hemostats in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Hemostats Market Size, 2019 VS 2023 VS 2030
1.3 Global Hemostats Market Size Estimates and Forecasts (2019-2030)
1.4 Global Hemostats Sales Estimates and Forecasts (2019-2030)
1.5 Global Hemostats Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Hemostats Market Dynamics
2.1 Hemostats Industry Trends
2.2 Hemostats Industry Drivers
2.3 Hemostats Industry Opportunities and Challenges
2.4 Hemostats Industry Restraints
3 Hemostats Market by Manufacturers
3.1 Global Hemostats Revenue by Manufacturers (2019-2024)
3.2 Global Hemostats Sales by Manufacturers (2019-2024)
3.3 Global Hemostats Average Sales Price by Manufacturers (2019-2024)
3.4 Global Hemostats Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Hemostats Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Hemostats Manufacturers, Product Type & Application
3.7 Global Hemostats Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Hemostats Market CR5 and HHI
3.8.2 Global Top 5 and 10 Hemostats Players Market Share by Revenue in 2023
3.8.3 2023 Hemostats Tier 1, Tier 2, and Tier 3
4 Hemostats Market by Type
4.1 Hemostats Type Introduction
4.1.1 Thrombin-Based Hemostats
4.1.2 Oxidized Regenerated Cellulose Based Hemostats
4.1.3 Combination Hemostats
4.1.4 Gelatin Based Hemostats
4.1.5 Collagen Based Hemostats
4.2 Global Hemostats Sales by Type
4.2.1 Global Hemostats Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Hemostats Sales by Type (2019-2030)
4.2.3 Global Hemostats Sales Market Share by Type (2019-2030)
4.3 Global Hemostats Revenue by Type
4.3.1 Global Hemostats Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Hemostats Revenue by Type (2019-2030)
4.3.3 Global Hemostats Revenue Market Share by Type (2019-2030)
5 Hemostats Market by Application
5.1 Hemostats Application Introduction
5.1.1 Prehospital Treatment
5.1.2 Hospital Treatment
5.2 Global Hemostats Sales by Application
5.2.1 Global Hemostats Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Hemostats Sales by Application (2019-2030)
5.2.3 Global Hemostats Sales Market Share by Application (2019-2030)
5.3 Global Hemostats Revenue by Application
5.3.1 Global Hemostats Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Hemostats Revenue by Application (2019-2030)
5.3.3 Global Hemostats Revenue Market Share by Application (2019-2030)
6 Global Hemostats Sales by Region
6.1 Global Hemostats Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Hemostats Sales by Region (2019-2030)
6.2.1 Global Hemostats Sales by Region (2019-2024)
6.2.2 Global Hemostats Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Hemostats Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Hemostats Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Hemostats Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Hemostats Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Hemostats Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Hemostats Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Hemostats Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Hemostats Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Hemostats Revenue by Region
7.1 Global Hemostats Revenue by Region
7.1.1 Global Hemostats Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Hemostats Revenue by Region (2019-2024)
7.1.3 Global Hemostats Revenue by Region (2025-2030)
7.1.4 Global Hemostats Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Hemostats Revenue (2019-2030)
7.2.2 North America Hemostats Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Hemostats Revenue (2019-2030)
7.3.2 Europe Hemostats Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Hemostats Revenue (2019-2030)
7.4.2 Asia-Pacific Hemostats Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Hemostats Revenue (2019-2030)
7.5.2 LAMEA Hemostats Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 Ethicon
8.1.1 Ethicon Comapny Information
8.1.2 Ethicon Business Overview
8.1.3 Ethicon Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Ethicon Hemostats Product Portfolio
8.1.5 Ethicon Recent Developments
8.2 Pfizer
8.2.1 Pfizer Comapny Information
8.2.2 Pfizer Business Overview
8.2.3 Pfizer Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Pfizer Hemostats Product Portfolio
8.2.5 Pfizer Recent Developments
8.3 Baxter International Inc.
8.3.1 Baxter International Inc. Comapny Information
8.3.2 Baxter International Inc. Business Overview
8.3.3 Baxter International Inc. Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Baxter International Inc. Hemostats Product Portfolio
8.3.5 Baxter International Inc. Recent Developments
8.4 C. R. Bard
8.4.1 C. R. Bard Comapny Information
8.4.2 C. R. Bard Business Overview
8.4.3 C. R. Bard Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 C. R. Bard Hemostats Product Portfolio
8.4.5 C. R. Bard Recent Developments
8.5 The Medicines Company
8.5.1 The Medicines Company Comapny Information
8.5.2 The Medicines Company Business Overview
8.5.3 The Medicines Company Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 The Medicines Company Hemostats Product Portfolio
8.5.5 The Medicines Company Recent Developments
8.6 Anika Therapeutics
8.6.1 Anika Therapeutics Comapny Information
8.6.2 Anika Therapeutics Business Overview
8.6.3 Anika Therapeutics Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Anika Therapeutics Hemostats Product Portfolio
8.6.5 Anika Therapeutics Recent Developments
8.7 Advanced Medical Solutions
8.7.1 Advanced Medical Solutions Comapny Information
8.7.2 Advanced Medical Solutions Business Overview
8.7.3 Advanced Medical Solutions Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Advanced Medical Solutions Hemostats Product Portfolio
8.7.5 Advanced Medical Solutions Recent Developments
8.8 Integra LifeSciences Corporation
8.8.1 Integra LifeSciences Corporation Comapny Information
8.8.2 Integra LifeSciences Corporation Business Overview
8.8.3 Integra LifeSciences Corporation Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Integra LifeSciences Corporation Hemostats Product Portfolio
8.8.5 Integra LifeSciences Corporation Recent Developments
8.9 B Braun Melsungen AG
8.9.1 B Braun Melsungen AG Comapny Information
8.9.2 B Braun Melsungen AG Business Overview
8.9.3 B Braun Melsungen AG Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 B Braun Melsungen AG Hemostats Product Portfolio
8.9.5 B Braun Melsungen AG Recent Developments
8.10 Gelita Medical GmbH
8.10.1 Gelita Medical GmbH Comapny Information
8.10.2 Gelita Medical GmbH Business Overview
8.10.3 Gelita Medical GmbH Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Gelita Medical GmbH Hemostats Product Portfolio
8.10.5 Gelita Medical GmbH Recent Developments
8.11 Equimedical
8.11.1 Equimedical Comapny Information
8.11.2 Equimedical Business Overview
8.11.3 Equimedical Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Equimedical Hemostats Product Portfolio
8.11.5 Equimedical Recent Developments
8.12 Vascular Solutions
8.12.1 Vascular Solutions Comapny Information
8.12.2 Vascular Solutions Business Overview
8.12.3 Vascular Solutions Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Vascular Solutions Hemostats Product Portfolio
8.12.5 Vascular Solutions Recent Developments
8.13 Marine Polymer Technologies
8.13.1 Marine Polymer Technologies Comapny Information
8.13.2 Marine Polymer Technologies Business Overview
8.13.3 Marine Polymer Technologies Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Marine Polymer Technologies Hemostats Product Portfolio
8.13.5 Marine Polymer Technologies Recent Developments
8.14 Z-Medica, LLC
8.14.1 Z-Medica, LLC Comapny Information
8.14.2 Z-Medica, LLC Business Overview
8.14.3 Z-Medica, LLC Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Z-Medica, LLC Hemostats Product Portfolio
8.14.5 Z-Medica, LLC Recent Developments
8.15 CryoLife
8.15.1 CryoLife Comapny Information
8.15.2 CryoLife Business Overview
8.15.3 CryoLife Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 CryoLife Hemostats Product Portfolio
8.15.5 CryoLife Recent Developments
8.16 BioCer Entwicklungs-GmbH.
8.16.1 BioCer Entwicklungs-GmbH. Comapny Information
8.16.2 BioCer Entwicklungs-GmbH. Business Overview
8.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.16.4 BioCer Entwicklungs-GmbH. Hemostats Product Portfolio
8.16.5 BioCer Entwicklungs-GmbH. Recent Developments
8.17 Biom'Up SAS
8.17.1 Biom'Up SAS Comapny Information
8.17.2 Biom'Up SAS Business Overview
8.17.3 Biom'Up SAS Hemostats Sales, Price, Revenue and Gross Margin (2019-2024)
8.17.4 Biom'Up SAS Hemostats Product Portfolio
8.17.5 Biom'Up SAS Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Hemostats Value Chain Analysis
9.1.1 Hemostats Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Hemostats Production Mode & Process
9.2 Hemostats Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Hemostats Distributors
9.2.3 Hemostats Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings